Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
July 28, 2016

They are trying to refranchise some of their bottling agreements and are 2/3rds of the way through. They should increase their margins.

Show full opinionHide full opinion

They are trying to refranchise some of their bottling agreements and are 2/3rds of the way through. They should increase their margins.

Andy Nasr

Unlock Ratings

Price
$143.940
Owned
Unknown
HOLD
HOLD
July 28, 2016

They generate a lot of cash. The stock has not done well because their Hep-C drug is very affective and the demand for the drug will go down. He would hang on and you should see the share price increase.

Show full opinionHide full opinion

They generate a lot of cash. The stock has not done well because their Hep-C drug is very affective and the demand for the drug will go down. He would hang on and you should see the share price increase.

BUY
BUY
July 28, 2016

REITs. H&R or Slate? They are creating a new sector at the end of the month. The incremental demand should support share prices. He prefers H&R to slate. Even if it has exposure to Western Canada, there are 10 years to the leases and to their debt. It is a very well diversified REIT and you get a great yield.

Show full opinionHide full opinion

REITs. H&R or Slate? They are creating a new sector at the end of the month. The incremental demand should support share prices. He prefers H&R to slate. Even if it has exposure to Western Canada, there are 10 years to the leases and to their debt. It is a very well diversified REIT and you get a great yield.

DON'T BUY
DON'T BUY
July 28, 2016

Significant emerging markets exposure. He sees better risk reward in other parts of the healthcare market.

Show full opinionHide full opinion
Abbott Labs (ABT-N)
July 28, 2016

Significant emerging markets exposure. He sees better risk reward in other parts of the healthcare market.

HOLD
HOLD
July 28, 2016

Lifecos have assets and liabilities. Part of the overhang is the long end of the interest rate curve going down. They are investigating having to hold more cash on the balance sheet. Notwithstanding, they have hedges in place that mitigate short term exposure. The valuation should stay range bound for the short term.

Show full opinionHide full opinion

Lifecos have assets and liabilities. Part of the overhang is the long end of the interest rate curve going down. They are investigating having to hold more cash on the balance sheet. Notwithstanding, they have hedges in place that mitigate short term exposure. The valuation should stay range bound for the short term.

Andy Nasr

Unlock Ratings

Price
$17.910
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
July 28, 2016

(Top Pick Jul 02/15, Up 38.81%) He is one of the largest shareholders. He thinks there is still significant upside as they recently completed a significant acquisition in HVAC.

Show full opinionHide full opinion
EnerCare Inc (ECI-T)
July 28, 2016

(Top Pick Jul 02/15, Up 38.81%) He is one of the largest shareholders. He thinks there is still significant upside as they recently completed a significant acquisition in HVAC.

PAST TOP PICK
PAST TOP PICK
July 28, 2016

(Top Pick Jul 02/15, Down 15.33%) The concern is cord cutting or cord shaving. He still holds it. There is still good franchises there. He would wait for the next couple of quarters to get comfortable with ESPN before increasing holdings. Pullbacks are a good place to add.

Show full opinionHide full opinion
Walt Disney (DIS-N)
July 28, 2016

(Top Pick Jul 02/15, Down 15.33%) The concern is cord cutting or cord shaving. He still holds it. There is still good franchises there. He would wait for the next couple of quarters to get comfortable with ESPN before increasing holdings. Pullbacks are a good place to add.